Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
Summary
That’s the idea behind Rani Therapeutics, a medical technology company that has developed a “robotic pill” and is financially backed by some of world’s biggest investors. Now that Rani has positive results from its first human test, Imran says the company is preparing for another Phase 1 clinical trial in coming months, this time with pills carrying needles and active drug. In preclinical tests, those companies are assessing how RaniPill’s delivery of their biologic drugs compares to subcutaneous injections. The main feedback Rani received was to demonstrate safety because the efficacy of the drugs the company is working with is already established. In clinical trials, Rani must show the body absorbs the same percentage of drug from RaniPill as it does from a subcutaneous injection.
Classifications
AskAI Classifications
LabelsLinked Companies
